Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:patches
|
| gptkbp:administered_by |
injection
licensed healthcare provider |
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:available_in |
syringe form
|
| gptkbp:can_be_combined_with |
gptkb:Botox
other fillers |
| gptkbp:can_cause |
gptkb:disease
tissue necrosis granuloma formation vascular occlusion |
| gptkbp:clinical_trial |
studied for efficacy
studied for safety |
| gptkbp:contains |
hyaluronic acid
|
| gptkbp:duration |
6 to 12 months
|
| https://www.w3.org/2000/01/rdf-schema#label |
Juvederm Ultra Plus XC
|
| gptkbp:is_available_in |
gptkb:various_countries
|
| gptkbp:is_considered |
cosmetic procedure
minimally invasive procedure safe when administered correctly |
| gptkbp:is_often_accompanied_by |
gptkb:Skin
chemical peels laser treatments |
| gptkbp:is_part_of |
anti-aging treatments
Juvederm product line |
| gptkbp:is_popular_in |
cosmetic dermatology
|
| gptkbp:is_recommended_for |
fine lines
deep wrinkles facial volume loss |
| gptkbp:is_subject_to |
gptkb:guidelines
regulatory approval |
| gptkbp:is_used_by |
aesthetic practitioners
|
| gptkbp:is_used_in |
aesthetic medicine
|
| gptkbp:marketed_as |
long-lasting
non-surgical solution |
| gptkbp:packaging |
single-use syringe
|
| gptkbp:produced_by |
gptkb:Allergan
|
| gptkbp:requires |
consultation
post-treatment care skilled practitioner |
| gptkbp:side_effect |
bruising
swelling redness pain at injection site |
| gptkbp:storage |
room temperature
|
| gptkbp:suitable_for |
pregnant women
people with bleeding disorders people with severe allergies nursing mothers people with skin infections |
| gptkbp:used_for |
facial wrinkles
lip augmentation |
| gptkbp:website |
lips
nasolabial folds |
| gptkbp:bfsParent |
gptkb:Juvederm
|
| gptkbp:bfsLayer |
6
|